Breakthrough in HIV Prevention: FDA Approves Twice-Yearly Injection
The US Food and Drug Administration (FDA) has approved a groundbreaking HIV prevention treatment, lenacapavir, marketed as Yeztugo, which requires ...
Read moreDetailsThe US Food and Drug Administration (FDA) has approved a groundbreaking HIV prevention treatment, lenacapavir, marketed as Yeztugo, which requires ...
Read moreDetails